It is a business services private limited company based in Patna, Bihar, India, established in 2017.
2017 | Patna, Bihar, India | ActivePeter & Walse Medicaments Private Limited, a active private limited company, was established on 26 October 2017 in Patna, Bihar, India. Engaging in other services within the business services sector, it holds CIN: U74999BR2017PTC036111. Registered under ROC Roc Patna. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Sheela Jaiswal (Director), Sahil Kumar (Director). Past directors included Sanjay Kumar Gupta, Dineshwar Singh Dadan. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at Sri Ram Palace Gandhi Nagar, Kankarbagh, Patna, Bihar, 800020.
U74999BR2017PTC036111
036111
26 October 2017
₹1.00 M
₹0.10 M
Roc Patna
Unlisted
Active
Explore comprehensive insights into Peter & Walse Medicaments Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sheela Jaiswal | Director | 26 Oct 2017 | Current |
| Sahil Kumar | Director | 24 Mar 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 24 Mar 2022 | Past |
| Pramod Abcsdd | Additional Director | 08 Jun 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Peter & Walse Medicaments's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Peter & Walse Medicaments's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Peter & Walse Medicaments, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Peter & Walse Medicaments, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Peter & Walse Medicaments's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Peter & Walse Medicaments Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was completed.
The activity Peter & Walse Medicaments Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Patna. was completed.
The activity Sahil Kumar was appointed as a Director was appointed as a Director on 24 Mar 2022 & has been associated with this company since 3 years 8 months . was completed.
Progress on Sheela Jaiswal was appointed as a Director was appointed as a Director on 26 Oct 2017 & has been associated with this company since 8 years 1 month . was documented.
Peter & Walse Medicaments Private Limited was registered on 26 Oct 2017 with Roc Patna & aged 8 years 1 month as per MCA records. was recorded as a recent event.
The CIN of Peter & Walse Medicaments Private Limited is U74999BR2017PTC036111.
Peter & Walse Medicaments Private Limited is headquartered at Sri Ram Palace Gandhi Nagar, Kankarbagh, Patna, Bihar, 800020.
Peter & Walse Medicaments Private Limited was incorporated on 26 October 2017.
The current directors of Peter & Walse Medicaments Private Limited are
The primary industry of Peter & Walse Medicaments Private Limited is Business Services.
Peter & Walse Medicaments Private Limited is unlisted.
The authorized capital of Peter & Walse Medicaments Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.
The compliance status of Peter & Walse Medicaments Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX